Friday, 20 December 2019

Stealth BioTherapeutics' neuromuscular disorder drug fails late-stage study

Stealth BioTherapeutics Corp said on Friday its drug to treat neuromuscular diseases failed to meet the main goals of a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)